ProspectiveTrial of Proton Beam Combined With Anti-VEGF Therapy for Exudative Age-related Macular Degeneration (AMD)

NCT01213082 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Exudative Age-related Macular Degeneration

Interventions

DRUG: 24GyE proton and Anti-VEGF
DRUG: 16GyE and anti-VEGF
DRUG: Sham Irradiation and anti-VEGF

Sponsor

University of California, Davis

Collaborators

[object Object]